Pardinas
Jose Pardinas, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110091971 | Differentiation of Pluripotent Stem Cells - The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage. The present invention also provides methods to generate and purify agents capable of differentiating pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage. | 04-21-2011 |
20110224086 | Methods and Algorithms for Selecting Polynucleotides For Synthetic Assembly - The present invention relates to methods and algorithms for identifying, synthesizing and co-assembling combinatorial libraries of polynucleotide variants. | 09-15-2011 |
Jose Pardinas, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20120093833 | Human Oncostatin M Antibodies and Methods of Use - Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis. | 04-19-2012 |
Jose Pardinas, Spring House, PA US
Patent application number | Description | Published |
---|---|---|
20140099315 | Human Oncostatin M Antibodies and Methods of Use - Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis. | 04-10-2014 |
20150087812 | Human Autotaxin Antibodies and Methods of Use - Antibodies and compositions capable of binding and, in a particular aspect, inhibiting the lysophosphatidylipase D activity of human autotaxin protein. The antibodies or are useful in detecting human autotaxin protein and treating diseases and disorders associated with unwanted lysophosphatidylipase D and the presence of lysophosphatidic acid, such as cancer and pulmonary diseases. | 03-26-2015 |